Restructure without losing the capability you still need

BEFORE THE DECISION

See what is at risk before it walks out

Title-based restructuring decisions can remove capability and relationships the organization still depends on, and they often surface only after the people holding them are gone.

You receive a map of critical capabilities and dependencies across Medical, Field, Clinical, Access, and Commercial; the knowledge and relationship risks in the current plan; and options to retain or redeploy what you still need.

Talmedica does not make or recommend individual selection decisions.

FOR AFFECTED EMPLOYEES

A transition built for pharma and biotech

Industry-specific transition support, informed by 20+ years building, leading, and hiring Medical Affairs and Field Medical teams.

Delivered in cohorts, so participants work alongside peers navigating the same market. Each cohort covers a market read on how their experience is perceived, positioning, and interview and presentation preparation, with self-paced access to Talmedica's transition tools, including the Market Signal Audit.

AS PEOPLE LEAVE

Protect what leaves with them

A structured handoff of critical knowledge and key relationships before departures, so the work and the stakeholders behind it stay covered.